Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

A BMP/activin A chimera is superior to native BMPs and induces bone repair in nonhuman primates when delivered in a composite matrix.

Seeherman HJ, Berasi SP, Brown CT, Martinez RX, Juo ZS, Jelinsky S, Cain MJ, Grode J, Tumelty KE, Bohner M, Grinberg O, Orr N, Shoseyov O, Eyckmans J, Chen C, Morales PR, Wilson CG, Vanderploeg EJ, Wozney JM.

Sci Transl Med. 2019 Apr 24;11(489). pii: eaar4953. doi: 10.1126/scitranslmed.aar4953.

PMID:
31019025
2.

Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.

Nikolic I, Yung LM, Yang P, Malhotra R, Paskin-Flerlage SD, Dinter T, Bocobo GA, Tumelty KE, Faugno AJ, Troncone L, McNeil ME, Huang X, Coser KR, Lai CSC, Upton PD, Goumans MJ, Zamanian RT, Elliott CG, Lee A, Zheng W, Berasi SP, Huard C, Morrell NW, Chung RT, Channick RW, Roberts KE, Yu PB.

Am J Respir Crit Care Med. 2019 Apr 1;199(7):891-902. doi: 10.1164/rccm.201807-1236OC.

PMID:
30312106
3.

Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways.

Tumelty KE, Higginson-Scott N, Fan X, Bajaj P, Knowlton KM, Shamashkin M, Coyle AJ, Lu W, Berasi SP.

J Biol Chem. 2018 Mar 2;293(9):3039-3055. doi: 10.1074/jbc.M117.804021. Epub 2018 Jan 9.

4.

SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion.

Fan X, Yang H, Kumar S, Tumelty KE, Pisarek-Horowitz A, Rasouly HM, Sharma R, Chan S, Tyminski E, Shamashkin M, Belghasem M, Henderson JM, Coyle AJ, Salant DJ, Berasi SP, Lu W.

JCI Insight. 2016 Nov 17;1(19):e86934. doi: 10.1172/jci.insight.86934.

5.

Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling.

Auld KL, Berasi SP, Liu Y, Cain M, Zhang Y, Huard C, Fukayama S, Zhang J, Choe S, Zhong W, Bhat BM, Bhat RA, Brown EL, Martinez RV.

J Mol Endocrinol. 2012 Mar 12;48(2):177-91. doi: 10.1530/JME-11-0140. Print 2012 Apr.

PMID:
22333182
6.

Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities.

Berasi SP, Varadarajan U, Archambault J, Cain M, Souza TA, Abouzeid A, Li J, Brown CT, Dorner AJ, Seeherman HJ, Jelinsky SA.

Growth Factors. 2011 Aug;29(4):128-39. doi: 10.3109/08977194.2011.593178. Epub 2011 Jun 27.

7.

Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer.

Paulson KE, Rieger-Christ K, McDevitt MA, Kuperwasser C, Kim J, Unanue VE, Zhang X, Hu M, Ruthazer R, Berasi SP, Huang CY, Giri D, Kaufman S, Dugan JM, Blum J, Netto G, Wazer DE, Summerhayes IC, Yee AS.

Cancer Res. 2007 Jul 1;67(13):6136-45.

8.

Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase.

Berasi SP, Huard C, Li D, Shih HH, Sun Y, Zhong W, Paulsen JE, Brown EL, Gimeno RE, Martinez RV.

J Biol Chem. 2006 Sep 15;281(37):27167-77. Epub 2006 Jul 18.

9.

The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression.

Yee AS, Paulson EK, McDevitt MA, Rieger-Christ K, Summerhayes I, Berasi SP, Kim J, Huang CY, Zhang X.

Gene. 2004 Jul 7;336(1):1-13. Review.

PMID:
15225871
10.

HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase.

Berasi SP, Xiu M, Yee AS, Paulson KE.

Mol Cell Biol. 2004 Apr;24(7):3011-24.

11.

HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue.

Shih HH, Xiu M, Berasi SP, Sampson EM, Leiter A, Paulson KE, Yee AS.

Mol Cell Biol. 2001 Sep;21(17):5723-32. Erratum in: Mol Cell Biol 2001 Nov;21(21):7535.

Supplemental Content

Loading ...
Support Center